Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells

Cellular Oncology

Volumn 36, Issue 1, 2013, Pages 65-77

  Serna Marquez, Nathalia ^a   Villegas Comonfort, Socrates ^a   Galindo Hernandez, Octavio ^a   Navarro Tito, Napoleon ^a   Millan, Alejandro ^b   Salazar, Eduardo Perez ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b Unidad de Investigación Especializada en Microbiologia   (Mexico)

Author keywords

Breast cancer; COX 2; FAK; Linoleic acid; LOXs; Migration

Indexed keywords

CYCLOOXYGENASE 2; FOCAL ADHESION KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; BIOCATALYSIS; BREAST CANCER; CANCER CELL CULTURE; CELL LYSATE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENE ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; LINOLEIC ACID; LINOLEOYL-COA DESATURASE; LIPOXYGENASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SIGNAL TRANSDUCTION;

EID: 84877074125     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0114-4     Document Type: Article

References (73)

1. M.P. Fay, L.S. Freedman, C.K. Clifford, D.N. Midthune, Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res. 57, 3979-3988 (1997)
2. M.M. Lee, S.S. Lin, Dietary fat and breast cancer. Annu. Rev. Nutr. 20, 221-248 (2000)
3. P. Ferre, The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53(Suppl 1), S43-50 (2004)
4. T. Yonezawa, K. Katoh, Y. Obara, Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem. Biophys. Res. Commun. 314, 805-809 (2004)
5. A. Soto-Guzman, N. Navarro-Tito, L. Castro-Sanchez, R. Martinez-Orozco, E.P. Salazar, Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin. Exp. Metastasis 27, 505-515 (2010)
6. A.P. Simopoulos, Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60, 502-507 (2006)
7. P.L. Zock, M.B. Katan, Linoleic acid intake and cancer risk: a review and meta-analysis. Am. J. Clin. Nutr. 68, 142-153 (1998)
8. A. Mantovani, P. Allavena, A. Sica, F. Balkwill, Cancer-related inflammation. Nature 454, 436-444 (2008)
9. D.P. Rose, J.M. Connolly, Stimulation of growth of human breast cancer cell lines in culture by linoleic acid. Biochem. Biophys. Res. Commun. 164, 277-283 (1989)
10. R. Espinosa-Neira, J. Mejia-Rangel, P. Cortes-Reynosa, E.P. Salazar, Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A. Int. J. Biochem. Cell Biol. 43, 1782-1791 (2011)
11. T. Yonezawa, S. Haga, Y. Kobayashi, K. Katoh, Y. Obara, Unsaturated fatty acids promote proliferation via ERK1/2 and Akt pathway in bovine mammary epithelial cells. Biochem. Biophys. Res. Commun. 367, 729-735 (2008)
12. C.H. Byon, R.W. Hardy, C. Ren, S. Ponnazhagan, D.R. Welch, J.M. McDonald, Y. Chen, Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Lab. Invest. 89, 1221-1228 (2009)
13. K.A. DeMali, K. Wennerberg, K. Burridge, Integrin signaling to the actin cytoskeleton. Curr. Opin. Cell Biol. 15, 572-582 (2003)
14. M.A. Wozniak, K. Modzelewska, L. Kwong, P.J. Keely, Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta 1692, 103-119 (2004)
15. J.T. Parsons, K.H. Martin, J.K. Slack, J.M. Taylor, S.A. Weed, Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19, 5606-5613 (2000)
16. D.D. Schlaepfer, C.R. Hauck, D.J. Sieg, Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71, 435-478 (1999)
17. M.D. Schaller, Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540, 1-21 (2001)
18. J. Zhao, J.L. Guan, Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 28, 35-49 (2009)
19. J.T. Parsons, Focal adhesion kinase: the first ten years. J. Cell Sci. 116, 1409-1416 (2003)
20. M.D. Schaller, J.D. Hildebrand, J.T. Parsons, Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. Mol. Biol. Cell 10, 3489-3505 (1999)
21. S.L. Bellis, J.T. Miller, C.E. Turner, Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem. 270, 17437-17441 (1995)
22. K. Tachibana, T. Urano, H. Fujita, Y. Ohashi, K. Kamiguchi, S. Iwata, H. Hirai, C. Morimoto, Tyrosine phosphorylation of Crk-associated substrates by focal adhesion kinase. A putative mechanism for the integrin-mediated tyrosine phosphorylation of Crk-associated substrates. J. Biol. Chem. 272, 29083-29090 (1997)
23. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976)
24. N. Navarro-Tito, T. Robledo, E.P. Salazar, Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Exp. Cell Res. 314, 3340-3355 (2008)
25. M.D. Schaller, C.A. Borgman, J.T. Parsons, Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell. Biol. 13, 785-791 (1993)
26. C.L. Abram, S.A. Courtneidge, Src family tyrosine kinases and growth factor signaling. Exp. Cell Res. 254, 1-13 (2000)
27. J.H. Hanke, J.P. Gardner, R.L. Dow, P.S. Changelian, W.H. Brissette, E.J. Weringer, B.A. Pollok, P.A. Connelly, Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695-701 (1996)
28. P.A. Nony, S.B. Kennett, W.C. Glasgow, K. Olden, J.D. Roberts, 15S-Lipoxygenase-2 mediates arachidonic acid-stimulated adhesion of human breast carcinoma cells through the activation of TAK1, MKK6, and p38 MAPK. J. Biol. Chem. 280, 31413-31419 (2005)
29. K. Seibert, J.L. Masferrer, P. Needleman, D. Salvemini, Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney. Br. J. Pharmacol. 117, 1016-1020 (1996)
30. G. Perez-Chacon, A.M. Astudillo, D. Balgoma, M.A. Balboa, J. Balsinde, Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases. Biochim. Biophys. Acta 1791, 1103-1113 (2009)
31. A.A. Farooqui, L.A. Horrocks, Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod. Nutr. Dev. 45, 613-631 (2005)
32. H. Sprecher, Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. Biophys. Acta 1486, 219-231 (2000)
33. U.N. Das, Essential fatty acids: biochemistry, physiology and pathology. Biotechnol. J. 1, 420-439 (2006)
34. M.G. Obukowicz, D.J. Welsch, W.J. Salsgiver, C.L. Martin-Berger, K.S. Chinn, K.L. Duffin, A. Raz, P. Needleman, Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J. Pharmacol. Exp. Ther. 287, 157-166 (1998)
35. S.D. Harmon, T.L. Kaduce, T.D. Manuel, A.A. Spector, Effect of the delta6-desaturase inhibitor SC-26196 on PUFA metabolism in human cells. Lipids 38, 469-476 (2003)
36. H. Harizi, J.B. Corcuff, N. Gualde, Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends. Mol. Med. 14, 461-469 (2008)
37. J. Moss, M. Vaughan, ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. Adv. Enzymol. Relat. Areas Mol. Biol. 61, 303-379 (1988)
38. M. Schulz, K. Hoffmann, C. Weikert, U. Nothlings, M.B. Schulze, H. Boeing, Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br. J. Nutr. 100, 942-946 (2008)
39. P.M. Kris-Etherton, D.S. Taylor, S. Yu-Poth, P. Huth, K. Moriarty, V. Fishell, R.L. Hargrove, G. Zhao, T.D. Etherton, Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71, 179S-188S (2000)
40. S.G. Anderson, T.A. Sanders, J.K. Cruickshank, Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension 53, 839-845 (2009)
41. N. Navarro-Tito, A. Soto-Guzman, L. Castro-Sanchez, R. Martinez-Orozco, E.P. Salazar, Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway. Int. J. Biochem. Cell Biol. 42, 306-317 (2010)
42. D.P. Rose, J.M. Connolly, X.H. Liu, Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res. 54, 6557-6562 (1994)
43. S. Hardy, G.G. St-Onge, E. Joly, Y. Langelier, M. Prentki, Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J. Biol. Chem. 280, 13285-13291 (2005)
44. J.T. Parsons, S.J. Parsons, Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr. Opin. Cell Biol. 9, 187-192 (1997)
45. C. Egan, A. Pang, D. Durda, H.C. Cheng, J.H. Wang, D.J. Fujita, Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. Oncogene 18, 1227-1237 (1999)
46. C. Jacobs, H. Rubsamen, Expression of pp 60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. Cancer Res. 43, 1696-1702 (1983)
47. A. Soto-Guzman, T. Robledo, M. Lopez-Perez, E.P. Salazar, Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells. Mol. Cell. Endocrinol. 294, 81-91 (2008)
48. J.D. Owen, P.J. Ruest, D.W. Fry, S.K. Hanks, Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol. Cell. Biol. 19, 4806-4818 (1999)
49. E.P. Salazar, E. Rozengurt, Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J. Biol. Chem. 276, 17788-17795 (2001)
50. A.R. Brash, Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274, 23679-23682 (1999)
51. Y. Urade, K. Watanabe, O. Hayaishi, Prostaglandin D, E, and F synthases. J. Lipid Mediat. Cell Signal. 12, 257-273 (1995)
52. D.P. Rose, J.M. Connolly, Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 50, 7139-7144 (1990)
53. J.H. Capdevila, J.R. Falck, R.C. Harris, Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41, 163-181 (2000)
54. D.W. Nebert, D.W. Russell, Clinical importance of the cytochromes P450. Lancet 360, 1155-1162 (2002)
55. Z.L. Wu, C.D. Sohl, T. Shimada, F.P. Guengerich, Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol. Pharmacol. 69, 2007-2014 (2006)
56. A. Kalsotra, C.M. Turman, Y. Kikuta, H.W. Strobel, Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol. Appl. Pharmacol. 199, 295-304 (2004)
57. C. Bandala, E. Floriano-Sanchez, N. Cardenas-Rodriguez, J. Lopez-Cruz, E. Lara-Padilla, RNA expression of cytochrome p450 in mexican women with breast cancer. Asian Pac. J. Cancer Prev. 13, 2647-2653 (2012)
58. L.Y. Chau, H.H. Tai, Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase. Biochem. Biophys. Res. Commun. 100, 1688-1695 (1981)
59. A. Dessen, Structure and mechanism of human cytosolic phospholipase A(2). Biochim. Biophys. Acta 1488, 40-47 (2000)
60. M.J. Rebecchi, S.N. Pentyala, Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80, 1291-1335 (2000)
61. P. Maloberti, F.C. Maciel, A.F. Castillo, R. Castilla, A. Duarte, M.F. Toledo, F. Meuli, P. Mele, C. Paz, E.J. Podesta, Enzymes involved in arachidonic acid release in adrenal and Leydig cells. Mol. Cell. Endocrinol. 265-266, 113-120 (2007)
62. P.M. Maloberti, A.B. Duarte, U.D. Orlando, M.E. Pasqualini, A.R. Solano, C. Lopez-Otin, E.J. Podesta, Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS One 5, e15540 (2010)
63. M.E. Monaco, C.J. Creighton, P. Lee, X. Zou, M.K. Topham, D.M. Stafforini, Expression of long-chain fatty Acyl-CoA synthetase 4 in breast and prostate cancers is associated with sex steroid hormone receptor negativity. Transl. Oncol. 3, 91-98 (2010)
64. D. Kerjaschki, Z. Bago-Horvath, M. Rudas, V. Sexl, C. Schneckenleithner, S. Wolbank, G. Bartel, S. Krieger, R. Kalt, B. Hantusch, T. Keller, K. Nagy-Bojarszky, N. Huttary, I. Raab, K. Lackner, K. Krautgasser, H. Schachner, K. Kaserer, S. Rezar, S. Madlener, C. Vonach, A. Davidovits, H. Nosaka, M. Hammerle, K. Viola, H. Dolznig, M. Schreiber, A. Nader, W. Mikulits, M. Gnant, S. Hirakawa, M. Detmar, K. Alitalo, S. Nijman, F. Offner, T.J. Maier, D. Steinhilber, G. Krupitza, Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J. Clin. Invest. 121, 2000-2012 (2011)
65. B. Liu, W.A. Khan, Y.A. Hannun, J. Timar, J.D. Taylor, S. Lundy, I. Butovich, K.V. Honn, 12(S)-hydroxyeicosatetraenoic acid and 13(S)- hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. Proc. Natl. Acad. Sci. U. S. A. 92, 9323-9327 (1995)
66. J.R. Vane, Y.S. Bakhle, R.M. Botting, Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38, 97-120 (1998)
67. D. Hwang, D. Scollard, J. Byrne, E. Levine, Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer. Inst. 90, 455-460 (1998)
68. G. Furstenberger, P. Krieg, K. Muller-Decker, A.J. Habenicht, What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int. J. Cancer 119, 2247-2254 (2006)
69. K.J. Schmitz, R. Callies, J. Wohlschlaeger, R. Kimmig, F. Otterbach, J. Bohr, H.S. Lee, A. Takeda, K.W. Schmid, H.A. Baba, Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways. J. Clin. Pathol. 59, 685-691 (2006)
70. G.S. Ranger, V. Thomas, A. Jewell, K. Mokbel, Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer. Anticancer. Res. 24, 2349-2351 (2004)
71. C.L. Bos, D.J. Richel, T. Ritsema, M.P. Peppelenbosch, H.H. Versteeg, Prostanoids and prostanoid receptors in signal transduction. Int. J. Biochem. Cell Biol. 36, 1187-1205 (2004)
72. L.J. Kornberg, Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 20, 745-752 (1998)
73. D.A. Hsia, S.K. Mitra, C.R. Hauck, D.N. Streblow, J.A. Nelson, D. Ilic, S. Huang, E. Li, G.R. Nemerow, J. Leng, K.S. Spencer, D.A. Cheresh, D.D. Schlaepfer, Differential regulation of cell motility and invasion by FAK. J. Cell Biol. 160, 753-767 (2003)